Prevalence of Nonalcoholic Steatohepatitis and Associated Fibrosis Stages Among US Adults Using Imaging-Based vs Biomarker-Based Noninvasive Tests
**Introduction:** Nonalcoholic fatty liver disease (NAFLD) is believed to be the most common chronic liver disease worldwide. Therapies are under development for nonalcoholic steatohepatitis (NASH), the progressive form of NAFLD, such that the prevalence of NASH with liver fibrosis, which is likely...
Saved in:
Main Authors: | Jesse Fishman, Tom O'Connell, Christina M. Parrinello, Jonathan J. Woolley, Eric Bercaw, Michael R. Charlton |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2024-02-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.92223 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Artificial Intelligence in Identifying Patients With Undiagnosed Nonalcoholic Steatohepatitis
by: Onur Baser, et al.
Published: (2024-09-01) -
Pilot application of an inflammation and physiological dysregulation index based on noninvasive salivary biomarkers
by: Andrey I. Egorov, et al.
Published: (2025-02-01) -
Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
by: D. V. Garbuzenko
Published: (2022-01-01) -
The impact of the ursodeoxycholic acid as monotherapy and in the combination with the lactulose on the biochemical blood tests values of the nonalcoholic steatohepatitis patients
by: I. V. Mayev, et al.
Published: (2013-03-01) -
Advancements in noninvasive techniques for transplant rejection: from biomarker detection to molecular imaging
by: Yuan Song, et al.
Published: (2025-02-01)